214
Purpose for Investment
Hempco's position within the hemp based nutrition space makes it a strategic partner and attractive acquisition candidate. Industrial hemp grown under contract to Hempco contains efficient extractable quantities of cannabidiol (CBD). Aurora expects the regulations that prevent industrial hemp producers from harvesting leaves, flowers and buds, which contain CBD to be revised to allow for the processing of it.
The market for CBDs in the form of capsules, oils, and topicals is expected to show significant growth, and Aurora considers the proposed transaction with Hempco to be a strategic initiative to enable market share dominance in this attractive segment.
Through its relationship with Radient Technologies (RTI.V), Aurora has access to technology that is capable of producing CBD-based products at large scale, thus providing the Company with a considerable competitive advantage in addressing this growing market when CBD extraction from hemp is allowed.
Invictus MD (TSX.V: IMH) (OTC: IVITF) Poised to Have First-Mover Advantage in Canada’s Legal Cannabis Market
-One of few Canadian cannabis companies to declare dividends.
-Poised for first-mover advantage in Canada’s legal marijuana market.
-250 acres of cultivation space spanning from Alberta to Ontario.
-Retail sales in Canada’s recreational marijuana market could climb to $6.0 billion by 2021, according to Deloitte Canadian, and Invictus MD Strategies Corp. (TSX.V: IMH) (OTC: IVITF) is strategically positioned to grow right alongside this burgeoning market and gain first-mover advantage as soon as Canada’s cannabis market is freed up by the necessary legislative regulations.
Tetra Bio-Pharma Strengthens its Position on Bringing Marijuana to Patients in a Form Acceptable to Health Care Professionals
Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(OTCQB: TBPMF), today announced that it has strengthened its position on bringing marijuana to patients in the form of a prescription drug. Tetra has become a world leader in the field of cannabis drug development and its PPP001 dried cannabis drug was covered in the Global Pain Management Drugs Market analysis report published by Azoth Analytics in May 2017. According to this report, Tetra is the only company developing dried marijuana as a drug.